Strong Therapeutic Potential of Γ-Secretase Inhibitor MRK003 for CD44-high and CD133-low Glioblastoma Initiating Cells

Journal of Neuro-Oncology - Netherlands
doi 10.1007/s11060-014-1630-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Gastric Tumor-Initiating CD44+ Cells and Epithelial-Mesenchymal Transition Are Inhibited by Γ-Secretase Inhibitor DAPT

Oncology Letters
Cancer ResearchOncology
2015English

Γ-Secretase Inhibitor–resistant Glioblastoma Stem Cells Require RBPJ to Propagate

Journal of Clinical Investigation
Medicine
2016English

Γ-Secretase-Dependent Proteolysis of CD44 Promotes Neoplastic Transformation of Rat Fibroblastic Cells

Cancer Research
Cancer ResearchOncology
2006English

CD133 Induces Tumour-Initiating Properties in HEK293 Cells

Tumor Biology
MedicineCancer Research
2012English

Γ-Secretase

Science-Business eXchange
2012English

A Γ-Secretase Inhibitor, but Not a Γ-Secretase Modulator, Induced Defects in BDNF Axonal Trafficking and Signaling: Evidence for a Role for APP

PLoS ONE
Multidisciplinary
2015English

Therapeutic Targeting of Constitutive PARP Activation Compromises Stem Cell Phenotype and Survival of Glioblastoma-Initiating Cells

Cell Death and Differentiation
Cell BiologyMolecular Biology
2013English

Γ-Secretase Inhibitor Reduces Immunosuppressive Cells and Enhances Tumour Immunity in Head and Neck Squamous Cell Carcinoma

International Journal of Cancer
Cancer ResearchOncology
2017English

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma

Clinical Medicine Insights: Oncology
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy